Cyclooxygenase inhibitors induce apoptosis in oral cavity cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene

Biochemical and Biophysical Research Communications

Volumn 325, Issue 4, 2004, Pages 1298-1303

  Kim, Kyung Su ^a   Yoon, Joo Heon ^a   Kim, Jin Kook ^b   Baek, Seung Joon ^c   Eling, Thomas E ^d   Lee, Won Jae ^e   Ryu, Ji Hwan ^e   Lee, Jeung Gweon ^a   Lee, Joo Hwan ^a   Yoo, Jong Bum ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c UNIVERSITY OF TENNESSEE   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e Ewha Womans University   (South Korea)

Author keywords

Apoptosis; Drosophila; Nonsteroidal anti inflammatory drugs; NSAID activated gene 1; Oral cavity cancer

Indexed keywords

ACECLOFENAC; DICLOFENAC; IBUPROFEN; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; PROSTAGLANDIN SYNTHASE INHIBITOR; SULINDAC SULFIDE;

APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; DROSOPHILA; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INCUBATION TIME; MOUTH CANCER; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE INHIBITORS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MOUTH; MOUTH NEOPLASMS; RECOMBINANT PROTEINS;

EID: 8844231184     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.10.176     Document Type: Article

References (20)

1. M.T. Canto, and S.S. Devesa Oral cavity and pharynx cancer incidence rates in the United States, 1975-1998 Oral Oncol. 38 2002 610 617
2. J. Mork Forty years of monitoring head and neck cancer in Norway-no good news Anticancer Res. 18 1998 3705 3708
3. P.A. Levine, and R.J. Hood Neoplasms of the oral cavity J.T. Johnson J.L. Gluckman A.M. Pou Head and Neck Surgery-Otolaryngology Third ed. 2001 Lippincott Williams & Wilkins Philadelphia 1311 1325
4. A.L. Rinaldi, M.A. Morse, H.W. Fields, D.A. Rothas, P. Pei, K.A. Rodrigo, R.J. Renner, and S.R. Mallery Curcumin activates the aryl hydrocarbon receptor yet significantly inhibits (-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiol bioactivation in oral squamous cell carcinoma cells and oral mucosa Cancer Res. 62 2002 5451 5456
5. J. Sudbo, M. Bryne, L. Mao, R. Lotan, A. Reith, W. Kildal, B. Davidson, T.M. Soland, and S.M. Lippman Molecular based treatment of oral cancer Oral Oncol. 39 2003 749 758
6. R. Hanif, A. Pittas, Y. Feng, M.I. Koutsos, L. Qiao, L. Staiano-Coico, S.I. Shiff, and B. Rigas Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway Biochem. Pharmacol. 52 1996 237 245
7. S.J. Shiff, M.I. Koutsos, L. Qiao, and B. Rigas Nonsteroidal anti-inflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis Exp. Cell. Res. 222 1996 179 188
8. S.J. Baek, K.S. Kim, J.B. Nixon, L.C. Wilson, and T.E. Eling Cyclooxygenase inhibitors regulate the expression of a TGF-β superfamily member that has proapoptotic and antitumorigenic activities Mol. Pharmacol. 59 2001 901 908
9. K.S. Kim, S.J. Baek, G.P. Flake, C.D. Loftin, B.F. Calvo, and T.E. Eling Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue Gastroenterology 122 2002 1388 1398
10. S.J. Baek, L.C. Wilson, C.H. Lee, and T.E. Eling Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene J. Pharmacol. Exp. Ther. 301 2002 1126 1131
11. L.C. Wilson, S.J. Baek, A. Call, and T.E. Eling Nonsteroidal anti-inflammatory drug-activated gene gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells Int. J. Cancer 105 2003 747 753
12. S.J. Baek, J.S. Kim, J.B. Nixon, R.P. DiAugustine, and T.E. Eling Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1 J. Biol. Chem. 279 2004 6883 6892
13. D. Newman, M. Sakaue, J.S. Koo, K.S. Kim, S.J. Baek, T.E. Eling, and A.M. Jetten Differential regulation of nonsteroidal anti-inflammatory drug-activated gene in normal human tracheobronchial epithelial and lung carcinoma cells by retinoids Mol. Pharmacol. 63 2003 557 564
14. S.J. Baek, L.C. Wilson, and T.E. Eling Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53 Carcinogenesis 23 2002 425 434
15. P.P. Di Nocera, and I.B. Dawid Transient expression of genes introduced into cultured cells of Drosophila Proc. Natl. Acad. Sci. USA 80 1983 7095 7098
16. M. Tan, Y. Wang, K. Guan, and Y. Sun PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway Proc. Natl. Acad. Sci. USA 97 2000 109 114
17. M.S. Kim, S.L. Li, C.N. Bertolami, H.M. Cherrick, and N.H. Park State of p53, Rb and DCC tumor suppressor genes in human oral cancer cell lines Anticancer Res. 13 1993 1405 1413
18. R. Lotan, P.G. Sacks, D. Lotan, and W.K. Hong Differential effects of retinoic acid on the in vitro growth and cell-surface glycoconjugates of 2 human head and neck squamous-cell carcinoma Int. J. Cancer 40 1987 224 229
19. R. Yamazaki, S. Kawai, T. Matsumoto, T. Matsuzaki, S. Hashimoto, T. Yokokura, R. Okamoto, T. Koshino, and Y. Mizushima Hydrolytic activity is essential for aceclofenac to inhibit cyclooxygenase in rheumatoid synovial cells J. Pharmacol. Exp. Ther. 289 1999 676 681
20. T. Liu, A.R. Bauskin, J. Zaunders, D.A. Brown, S. Pankhurst, P.J. Russell, and S.N. Breit Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells Cancer Res. 63 2003 5034 5040